{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:01:46Z","timestamp":1792803706052,"version":"4.5.0"},"reference-count":120,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institutes of Health (NIH)","award":["ZIE DK 04705313"],"award-info":[{"award-number":["ZIE DK 04705313"]}],"id":[{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Thyroid cancer is a very common endocrine system malignancy. Nevertheless, a dearth of precise markers makes it challenging to apply precision medicine to thyroid cancer. The limitations of standard diagnosis techniques (fine-needle aspiration biopsy), such as indeterminate cases and inaccuracies in distinguishing between different types of cancers, lead to unnecessary surgeries and thus warrant the development of more discriminatory biomarkers to improve the accuracy of existing diagnostic and prognostic techniques. Moreover, individualized therapies for thyroid cancer are necessary to avoid overtreatment of indolent lesions and undertreatment of high-risk progressive disease. As thyroid cancer metabolic signatures are associated with disease aggressiveness and responsiveness to therapy, metabolomics has been recently used for diagnostic and prognostic biomarker discovery. This strategy has enabled the detection of several metabolites from tissue samples or biofluids to facilitate the classification of disease aggressiveness and to potentially assist in individualized therapies. In this review, we summarize the utilization and potential of metabolomics in thyroid cancer.<\/jats:p>","DOI":"10.3390\/cancers17061017","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:02:40Z","timestamp":1742277760000},"page":"1017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Emerging Potential of Metabolomics in Thyroid Cancer\u2014A Comprehensive Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-9972","authenticated-orcid":false,"given":"Sonam","family":"Kumari","sequence":"first","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Makarewicz","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-4420","authenticated-orcid":false,"given":"Joanna","family":"Klubo-Gwiezdzinska","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","article-title":"Thyroid cancer epidemiology and prognostic variables","volume":"22","author":"Sipos","year":"2010","journal-title":"Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Kondo","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/105072502761016502","article-title":"Risk factors for goiter and thyroid nodules","volume":"12","author":"Knudsen","year":"2002","journal-title":"Thyroid."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Albi, E., Cataldi, S., Lazzarini, A., Codini, M., Beccari, T., Ambesi-Impiombato, F.S., and Curcio, F. (2017). Radiation and Thyroid Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050911"},{"key":"ref_6","unstructured":"Society, A.C. (2025, March 16). Cancer Facts & Figures. Available online: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2025\/2025-cancer-facts-and-figures-acs.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00383-019-04584-0","article-title":"Metabolomics as a potential method for predicting thyroid malignancy in children and adolescents","volume":"36","author":"Zhou","year":"2020","journal-title":"Pediatr. Surg. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/JOE-17-0266","article-title":"Key signaling pathways in thyroid cancer","volume":"235","author":"Zaballos","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1089\/thy.2009.0274","article-title":"The Bethesda System for Reporting Thyroid Cytopathology","volume":"19","author":"Cibas","year":"2009","journal-title":"Thyroid"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/cncr.22955","article-title":"Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations","volume":"111","author":"Yang","year":"2007","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jasc.2023.05.005","article-title":"The 2023 Bethesda System for reporting thyroid cytopathology","volume":"12","author":"Ali","year":"2023","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.23116","article-title":"Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation","volume":"111","author":"Yassa","year":"2007","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda System for Reporting Thyroid Cytopathology: A meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy rate in thyroid nodules classified as Bethesda category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e230114","DOI":"10.1530\/ETJ-23-0114","article-title":"Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing","volume":"12","author":"Mavromati","year":"2023","journal-title":"Eur. Thyroid. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hannoush, Z.C., Ruiz-Cordero, R., Jara, M., and Kargi, A.Y. (2024). Current State of Molecular Cytology in Thyroid Nodules: Platforms and Their Diagnostic and Theranostic Utility. J. Clin. Med., 13.","DOI":"10.20944\/preprints202401.2065.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e230067","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur. Thyroid J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"19160216241291806","DOI":"10.1177\/19160216241291806","article-title":"Cost-Effectiveness Analysis of Molecular Testing for Indeterminate Thyroid Nodules in Nova Scotia","volume":"53","author":"MacKay","year":"2024","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2019Metabonomics\u2019: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"258763","DOI":"10.1155\/2015\/258763","article-title":"Application of metabolomics in thyroid cancer research","volume":"2015","author":"Wojakowska","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical applications of metabolomics in oncology: A review","volume":"15","author":"Spratlin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/gm336","article-title":"Metabolomics of human breast cancer: New approaches for tumor typing and biomarker discovery","volume":"4","author":"Denkert","year":"2012","journal-title":"Genome Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Thysell, E., Surowiec, I., H\u00f6rnberg, E., Crnalic, S., Widmark, A., Johansson, A.I., Stattin, P., Bergh, A., Moritz, T., and Antti, H. (2010). Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014175"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ab.2007.01.028","article-title":"A comprehensive urinary metabolomic approach for identifying kidney cancerr","volume":"363","author":"Kind","year":"2007","journal-title":"Anal. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mrm.10367","article-title":"Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy","volume":"49","author":"Howe","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2012.02.009","article-title":"Metabolomics in cancer: A bench-to-bedside intersection","volume":"84","author":"Claudino","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.surg.2012.08.037","article-title":"Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study","volume":"152","author":"Miccoli","year":"2012","journal-title":"Surgery"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cancers2020885","article-title":"The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature","volume":"2","author":"Grogan","year":"2010","journal-title":"Cancers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.trsl.2015.01.005","article-title":"Exhaled breath volatile biomarker analysis for thyroid cancer","volume":"166","author":"Guo","year":"2015","journal-title":"Transl. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1007\/s13277-016-4996-z","article-title":"Metabolomics of papillary thyroid carcinoma tissues: Potential biomarkers for diagnosis and promising targets for therapy","volume":"37","author":"Shang","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3892\/ijmm.2015.2368","article-title":"GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue","volume":"36","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrd1776","article-title":"The emerging field of lipidomics","volume":"4","author":"Wenk","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mas.21510","article-title":"Phospholipids as cancer biomarkers: Mass spectrometry-based analysis","volume":"37","author":"Bandu","year":"2018","journal-title":"Mass. Spectrom. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","article-title":"Progress in molecular-based management of differentiated thyroid cancer","volume":"381","author":"Xing","year":"2013","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/jc.2009-0308","article-title":"Proteomics in thyroid tumor research","volume":"94","author":"Krause","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jcp.22187","article-title":"Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications","volume":"224","author":"Carpi","year":"2010","journal-title":"J. Cell Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted Metabolomics Strategies-Challenges and Emerging Directions","volume":"27","author":"Codreanu","year":"2016","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1007\/s00216-014-7846-0","article-title":"Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption\/ionization-Fourier transform ion cyclotron resonance mass spectrometry","volume":"406","author":"Guo","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Deja, S., Dawiskiba, T., Balcerzak, W., Orczyk-Pawi\u0142owicz, M., G\u0142\u00f3d, M., Pawe\u0142ka, D., and M\u0142ynarz, P. (2013). Follicular adenomas exhibit a unique metabolic profile. \u00b9H NMR studies of thyroid lesions. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084637"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11306-009-0168-0","article-title":"Mass-spectrometry-based metabolomics: Limitations and recommendations for future progress with particular focus on nutrition research","volume":"5","author":"Scalbert","year":"2009","journal-title":"Metabolomics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/metabo3030552","article-title":"A review of applications of metabolomics in cancer","volume":"3","author":"Beger","year":"2013","journal-title":"Metabolites"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pnmrs.2014.09.001","article-title":"NMR-based metabolomics: From sample preparation to applications in nutrition research","volume":"83","author":"Brennan","year":"2014","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/pr060464h","article-title":"Tumour metabolomics in animal models of human cancer","volume":"6","author":"Griffin","year":"2007","journal-title":"J. Proteome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/cphc.200900133","article-title":"Recent advances in solution NMR: Fast methods and heteronuclear direct detection","volume":"10","author":"Felli","year":"2009","journal-title":"Chemphyschem"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpba.2018.07.024","article-title":"Metabolic fingerprinting in breast cancer stages through (1)H NMR spectroscopy-based metabolomic analysis of plasma","volume":"160","author":"Suman","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1039\/C8AN01310A","article-title":"Diagnosis of pancreatic cancer via(1)H NMR metabolomics of human plasma","volume":"143","year":"2018","journal-title":"Analyst"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ijc.28949","article-title":"An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients","volume":"136","author":"An","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_50","first-page":"119","article-title":"Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"Brooks","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nagayama, Y., and Hamada, K. (2022). Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer. Metabolites, 12.","DOI":"10.3390\/metabo12121214"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-01904-1","article-title":"Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation","volume":"65","author":"Abooshahab","year":"2019","journal-title":"Endocrine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Abooshahab, R., Ardalani, H., Zarkesh, M., Hooshmand, K., Bakhshi, A., Dass, C.R., and Hedayati, M. (2022). Metabolomics-A Tool to Find Metabolism of Endocrine Cancer. Metabolites, 12.","DOI":"10.3390\/metabo12111154"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Coelho, M., Raposo, L., Goodfellow, B.J., Atzori, L., Jones, J., and Manadas, B. (2020). The Potential of Metabolomics in the Diagnosis of Thyroid Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155272"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Neto, V., Esteves-Ferreira, S., In\u00e1cio, I., Alves, M., Dantas, R., Almeida, I., Guimar\u00e3es, J., Azevedo, T., and Nunes, A. (2022). Metabolic Profile Characterization of Different Thyroid Nodules Using FTIR Spectroscopy: A Review. Metabolites, 12.","DOI":"10.3390\/metabo12010053"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e7184","DOI":"10.1002\/cam4.7184","article-title":"Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis","volume":"13","author":"Razavi","year":"2024","journal-title":"Cancer Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Razavi, S.A., Kalari, M., Haghzad, T., Haddadi, F., Nasiri, S., and Hedayati, M. (2024). Exploring the potential of myo-inositol in thyroid disease management: Focus on thyroid cancer diagnosis and therapy. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1418956"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lan, L., Luo, Y., Zhou, M., Huo, L., Chen, H., Zuo, Q., and Deng, W. (2020). Comparison of Diagnostic Accuracy of Thyroid Cancer with Ultrasound-Guided Fine-Needle Aspiration and Core-Needle Biopsy: A Systematic Review and Meta-Analysis. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00044"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Razavi, S.A., Mahmanzar, M., Gh, B.F.N.M., Zamani, Z., Nasiri, S., and Hedayati, M. (2024). Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted 1H NMR-based metabolomics. J. Pharm. Biomed. Anal., 241.","DOI":"10.1016\/j.jpba.2023.115946"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41388-022-02254-5","article-title":"Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer","volume":"41","author":"Yu","year":"2022","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"D\u2019Andr\u00e9a, G., Jing, L., Peyrottes, I., Guigonis, J.M., Graslin, F., Lindenthal, S., Sanglier, J., Gimenez, I., Haudebourg, J., and Vandersteen, C. (2023). Pilot Study on the Use of Untargeted Metabolomic Fingerprinting of Liquid-Cytology Fluids as a Diagnostic Tool of Malignancy for Thyroid Nodules. Metabolites, 13.","DOI":"10.3390\/metabo13070782"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11306-018-1437-6","article-title":"Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics","volume":"14","author":"Rezig","year":"2018","journal-title":"Metabolomics"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ryoo, I., Kwon, H., Kim, S.C., Jung, S.C., Yeom, J.A., Shin, H.S., Cho, H.R., Yun, T.J., Choi, S.H., and Sohn, C.H. (2016). Metabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: Potential application for the preoperative diagnosis of thyroid cancer. Sci. Rep., 6.","DOI":"10.1038\/srep30075"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/pr300105e","article-title":"Toward the reliable diagnosis of indeterminate thyroid lesions: A HRMAS NMR-based metabolomics case of study","volume":"11","author":"Torregrossa","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Planque, M., Igelmann, S., Ferreira Campos, A.M., and Fendt, S.-M. (2023). Spatial metabolomics principles and application to cancer research. Curr. Opin. Chem. Biol., 76.","DOI":"10.1016\/j.cbpa.2023.102362"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e70031","DOI":"10.1002\/ctm2.70031","article-title":"Spatially resolved metabolomics: From metabolite mapping to function visualising","volume":"14","author":"Min","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.a2018.0003","article-title":"Discrimination of papillary thyroid cancer from non-cancerous thyroid tissue based on lipid profiling by mass spectrometry imaging","volume":"69","author":"Wojakowska","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21401","DOI":"10.1073\/pnas.1911333116","article-title":"Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies","volume":"116","author":"DeHoog","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wallace, E.N., West, C.A., McDowell, C.T., Lu, X., Bruner, E., Mehta, A.S., Aoki-Kinoshita, K.F., Angel, P.M., and Drake, R.R. (2024). An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry. Sci. Rep., 14.","DOI":"10.1038\/s41598-023-50957-w"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Mao, X., Huang, L., Li, T., Abliz, Z., He, J., and Chen, J. (2023). Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging. Molecules, 28.","DOI":"10.20944\/preprints202306.1101.v1"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2147\/CMAR.S188661","article-title":"Oncometabolites as biomarkers in thyroid cancer: A systematic review","volume":"11","author":"Khatami","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"113936","DOI":"10.1016\/j.yexcr.2024.113936","article-title":"Thyroid cancer cell metabolism: A glance into cell culture system-based metabolomics approaches","volume":"435","author":"Abooshahab","year":"2024","journal-title":"Exp. Cell Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Berinde, G.M., Socaciu, A.I., Socaciu, M.A., Petre, G.E., Socaciu, C., and Piciu, D. (2024). Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI(+)-MS Analysis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063495"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Berinde, G.M., Socaciu, A.I., Socaciu, M.A., Petre, G.E., Rajnoveanu, A.G., Barsan, M., Socaciu, C., and Piciu, D. (2024). In Search of Relevant Urinary Biomarkers for Thyroid Papillary Carcinoma and Benign Thyroid Nodule Differentiation, Targeting Metabolic Profiles and Pathways via UHPLC-QTOF-ESI(+)-MS Analysis. Diagnostics, 14.","DOI":"10.3390\/diagnostics14212421"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11306-024-02119-w","article-title":"Identifying potential breath biomarkers for early diagnosis of papillary thyroid cancer based on solid-phase microextraction gas chromatography-high resolution mass spectrometry with metabolomics","volume":"20","author":"Li","year":"2024","journal-title":"Metabolomics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"122729","DOI":"10.1016\/j.talanta.2021.122729","article-title":"Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry","volume":"235","author":"Zhang","year":"2021","journal-title":"Talanta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/ERC-19-0344","article-title":"Metabolite analysis-aided diagnosis of papillary thyroid cancer","volume":"26","author":"Chen","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1354750X.2024.2445258","article-title":"Study on identification of diagnostic biomarkers in serum for papillary thyroid cancer in different iodine nutrition regions","volume":"30","author":"Liu","year":"2024","journal-title":"Biomarkers"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"109203","DOI":"10.1016\/j.envint.2024.109203","article-title":"Serum metabolome associated with novel and legacy per- and polyfluoroalkyl substances exposure and thyroid cancer risk: A multi-module integrated analysis based on machine learning","volume":"195","author":"Wang","year":"2024","journal-title":"Environ. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10653-024-02158-1","article-title":"Identification of serum metabolites associated with polybrominated diphenyl ethers (PBDEs) exposure in papillary thyroid carcinoma: A case-control study","volume":"46","author":"Song","year":"2024","journal-title":"Environ. Geochem. Health"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s12020-024-04105-7","article-title":"Non-invasive diagnosis of papillary thyroid microcarcinoma using a novel metabolomics analysis of urine","volume":"87","author":"Zhao","year":"2024","journal-title":"Endocrine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2015.09.021","article-title":"Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC\/MS approach","volume":"417","author":"Wojakowska","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO Classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1158\/1078-0432.CCR-23-2025","article-title":"Integrative Multi-omics Analysis Reveals Different Metabolic Phenotypes Based on Molecular Characteristics in Thyroid Cancer","volume":"30","author":"Kim","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.surg.2016.04.050","article-title":"Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas","volume":"161","author":"Chai","year":"2017","journal-title":"Surgery"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/abbs\/gmab145","article-title":"Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer","volume":"53","author":"Wen","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3803\/EnM.2020.819","article-title":"Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer","volume":"36","author":"Ban","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_89","first-page":"323","article-title":"Construction and evaluation of a prognosis prediction model for thyroid carcinoma based on lipid metabolism-related genes","volume":"43","author":"Wang","year":"2022","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3803\/EnM.2020.35.2.227","article-title":"Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer","volume":"35","author":"Enomoto","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","article-title":"FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner","volume":"41","author":"Huang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41467-024-45366-0","article-title":"Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12935-024-03275-8","article-title":"LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC","volume":"24","author":"Huang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Xu, B., Gao, W., Xu, T., Liu, C., Wu, D., and Tang, W. (2022). A UPLC Q-Exactive Orbitrap Mass Spectrometry-Based Metabolomic Study of Serum and Tumor Tissue in Patients with Papillary Thyroid Cancer. Toxics, 11.","DOI":"10.3390\/toxics11010044"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Seo, J.W., Han, K., Lee, J., Kim, E.K., Moon, H.J., Yoon, J.H., Park, V.Y., Baek, H.M., and Kwak, J.Y. (2018). Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193883"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/cen.13437","article-title":"A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma","volume":"87","author":"Shen","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1298","DOI":"10.1002\/ctm2.1298","article-title":"Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer","volume":"13","author":"Sawant","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ouyang, J., Feng, Y., Zhang, Y., Liu, Y., Li, S., Wang, J., Tan, L., and Zou, L. (2023). Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication. Biomed. Pharmacother., 168.","DOI":"10.1016\/j.biopha.2023.115659"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1158\/1078-0432.CCR-17-3167","article-title":"Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo","volume":"24","author":"Thakur","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zheng, W., Tang, X., Dong, J., Feng, J., Chen, M., and Zhu, X. (2024). Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61067-6"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e1120","DOI":"10.1093\/oncolo\/oyae075","article-title":"Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma","volume":"29","author":"Wang","year":"2024","journal-title":"Oncologist"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"125629","DOI":"10.1016\/j.envpol.2025.125629","article-title":"Per- and polyfluoroalkyl substances (PFAS) exposure is associated with radioiodine therapy resistance and dedifferentiation of differentiated thyroid cancer","volume":"367","author":"Yu","year":"2025","journal-title":"Environ. Pollut."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Lu, G., Gao, D., Liu, Y., Yu, X., Jiang, W., and Lv, Z. (2024). Early and long-term responses of intestinal microbiota and metabolites to (131)I treatment in differentiated thyroid cancer patients. BMC Med., 22.","DOI":"10.1186\/s12916-024-03528-3"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00259-024-06688-9","article-title":"Disrupted gut microecology after high-dose (131)I therapy and radioprotective effects of arachidonic acid supplementation","volume":"51","author":"Lu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/ve.2024.0020","article-title":"Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer","volume":"11","author":"Kumari","year":"2024","journal-title":"VideoEndocrinology\u2122"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100996","DOI":"10.1016\/j.neo.2024.100996","article-title":"Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms","volume":"52","author":"Xu","year":"2024","journal-title":"Neoplasia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CAD.0000000000001626","article-title":"Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancer","volume":"35","author":"Liu","year":"2024","journal-title":"Anticancer Drugs"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lin, Y.H., Lin, Y.C., and Chen, C.C. (2021). Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials. Cells, 10.","DOI":"10.3390\/cells10071629"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kuang, A., Kouznetsova, V.L., Kesari, S., and Tsigelny, I.F. (2023). Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics. Metabolites, 14.","DOI":"10.3390\/metabo14010011"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Kurashige, T., Shimamura, M., Hamada, K., Matsuse, M., Mitsutake, N., and Nagayama, Y. (2023). Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-27461-2"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kumari, S., Adewale, R., and Klubo-Gwiezdzinska, J. (2020). The Molecular Landscape of H\u00fcrthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function\u2014A Comprehensive Review. Cells, 9.","DOI":"10.3390\/cells9071570"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Tronci, L., Serreli, G., Piras, C., Frau, D.V., Dettori, T., Deiana, M., Murgia, F., Santoru, M.L., Spada, M., and Leoni, V.P. (2021). Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines. Antioxidants, 10.","DOI":"10.3390\/antiox10050809"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"21336","DOI":"10.1021\/acsnano.4c05700","article-title":"High-Performance Metabolic Profiling of High-Risk Thyroid Nodules by ZrMOF Hybrids","volume":"18","author":"Chen","year":"2024","journal-title":"ACS Nano"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"112377","DOI":"10.1016\/j.mce.2024.112377","article-title":"Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation","volume":"594","author":"Cristiani","year":"2024","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Yang, H., Liang, Q., Zhang, J., Liu, J., Wei, H., Chen, H., Wei, W., Chen, D., and Zhao, Y. (2023). Establishment of papillary thyroid cancer organoid lines from clinical specimens. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1140888"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/clinem\/dgab020","article-title":"Organoid Cultures Derived from Patients with Papillary Thyroid Cancer","volume":"106","author":"Chen","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","first-page":"11","article-title":"Omics sciences and precision medicine in thyroid cancer","volume":"174","author":"Dhuli","year":"2023","journal-title":"Clin. Ter."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Al-Jundi, M., Thakur, S., Gubbi, S., and Klubo-Gwiezdzinska, J. (2020). Novel Targeted Therapies for Metastatic Thyroid Cancer\u2014A Comprehensive Review. Cancers, 12.","DOI":"10.3390\/cancers12082104"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Boufraqech, M., and Nilubol, N. (2019). Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome. Cancers, 11.","DOI":"10.3390\/cancers11121988"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Gulfidan, G., Soylu, M., Demirel, D., Erdonmez, H.B.C., Beklen, H., Ozbek Sarica, P., Arga, K.Y., and Turanli, B. (2022). Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks. Arch. Biochem. Biophys., 715.","DOI":"10.1016\/j.abb.2021.109085"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/1017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:47Z","timestamp":1760028947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/6\/1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":120,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cancers17061017"],"URL":"https:\/\/doi.org\/10.3390\/cancers17061017","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]}}}